ID   PAG15_HUMAN             Reviewed;         412 AA.
AC   Q8NCC3; B3KMF3; B4DUD1; Q53GZ1; Q9NPQ6; Q9UG04; Q9Y2B3;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   10-MAY-2017, entry version 135.
DE   RecName: Full=Group XV phospholipase A2;
DE            EC=2.3.1.- {ECO:0000269|PubMed:11790796, ECO:0000269|PubMed:20410020, ECO:0000269|PubMed:23958596, ECO:0000269|PubMed:25727495};
DE   AltName: Full=1-O-acylceramide synthase {ECO:0000303|PubMed:11790796};
DE            Short=ACS;
DE   AltName: Full=LCAT-like lysophospholipase {ECO:0000303|PubMed:10092508};
DE            Short=LLPL {ECO:0000303|PubMed:10092508};
DE   AltName: Full=Lysophospholipase 3;
DE   AltName: Full=Lysosomal phospholipase A2 {ECO:0000303|PubMed:11790796, ECO:0000303|PubMed:23958596};
DE            Short=LPLA2 {ECO:0000303|PubMed:11790796, ECO:0000303|PubMed:23958596};
DE   Flags: Precursor;
GN   Name=PLA2G15; Synonyms=LYPLA3; ORFNames=UNQ341/PRO540;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 34-43,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND FUNCTION.
RC   TISSUE=Heart, and Kidney;
RX   PubMed=10092508; DOI=10.1006/bbrc.1999.0411;
RA   Taniyama Y., Shibata S., Kita S., Horikoshi K., Shirafuji H.,
RA   Sumino Y., Fujino M.;
RT   "Cloning and expression of a novel lysophospholipase which
RT   structurally resembles lecithin cholesterol acyltransferase.";
RL   Biochem. Biophys. Res. Commun. 257:50-56(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 34-48.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 221-412 (ISOFORM 1).
RG   The European IMAGE consortium;
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   GLYCOSYLATION, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=11790796; DOI=10.1074/jbc.M111977200;
RA   Hiraoka M., Abe A., Shayman J.A.;
RT   "Cloning and characterization of a lysosomal phospholipase A2, 1-O-
RT   acylceramide synthase.";
RL   J. Biol. Chem. 277:10090-10099(2002).
RN   [12]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=20410020; DOI=10.1194/jlr.D007146;
RA   Abe A., Kelly R., Shayman J.A.;
RT   "The measurement of lysosomal phospholipase A2 activity in plasma.";
RL   J. Lipid Res. 51:2464-2470(2010).
RN   [13]
RP   GLYCOSYLATION, FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF ASN-99; ASN-273; ASN-289 AND ASN-398.
RX   PubMed=23958596; DOI=10.1194/jlr.M041640;
RA   Hiraoka M., Okamoto K., Ohguro H., Abe A.;
RT   "Role of N-glycosylation of human lysosomal phospholipase A2 for the
RT   formation of catalytically active enzyme.";
RL   J. Lipid Res. 54:3098-3105(2013).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.84 ANGSTROMS) OF 34-412 IN COMPLEX WITH
RP   SYNTHETIC INHIBITOR, CATALYTIC ACTIVITY, FUNCTION, ACTIVE SITE,
RP   SUBCELLULAR LOCATION, DISULFIDE BOND, MUTAGENESIS OF ASP-46; LEU-83;
RP   VAL-85; SER-198; LYS-235 AND THR-362, AND GLYCOSYLATION AT ASN-99;
RP   ASN-273; ASN-289 AND ASN-398.
RX   PubMed=25727495; DOI=10.1038/ncomms7250;
RA   Glukhova A., Hinkovska-Galcheva V., Kelly R., Abe A., Shayman J.A.,
RA   Tesmer J.J.;
RT   "Structure and function of lysosomal phospholipase A2 and
RT   lecithin:cholesterol acyltransferase.";
RL   Nat. Commun. 6:6250-6250(2015).
CC   -!- FUNCTION: Has transacylase and calcium-independent phospholipase
CC       A2 activity (PubMed:20410020, PubMed:23958596). Catalyzes the
CC       formation of 1-O-acyl-N-acetylsphingosine and the concomitant
CC       release of a lyso-phospholipid (PubMed:11790796, PubMed:25727495).
CC       Has high activity with 1-palmitoyl-2-oleoyl-sn-glycero-3-
CC       phosphocholine (POPC) and 1,2-dioleoyl-sn-glycero-3-phosphocholine
CC       (DOPC), catalyzing the transfer of oleic acid to N-acetyl-
CC       sphingosine. Required for normal phospholipid degradation in
CC       alveolar and peritoneal macrophages and in spleen (By similarity).
CC       May have weak lysophospholipase activity (PubMed:10092508).
CC       {ECO:0000250|UniProtKB:Q8VEB4, ECO:0000269|PubMed:10092508,
CC       ECO:0000269|PubMed:11790796, ECO:0000269|PubMed:20410020,
CC       ECO:0000269|PubMed:23958596, ECO:0000269|PubMed:25727495}.
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:23958596}.
CC       Secreted {ECO:0000269|PubMed:10092508,
CC       ECO:0000269|PubMed:20410020}. Membrane
CC       {ECO:0000269|PubMed:25727495}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:25727495}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NCC3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NCC3-2; Sequence=VSP_056689, VSP_056690;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in blood plasma (at protein level)
CC       (PubMed:10092508, PubMed:20410020). Ubiquitous. Highly expressed
CC       in heart, placenta, skeletal muscle, kidney and pancreas. Detected
CC       at lower levels in spleen, thymus, prostate, testis, ovary, small
CC       intestine, colon and peripheral blood leukocytes
CC       (PubMed:10092508). {ECO:0000269|PubMed:10092508,
CC       ECO:0000269|PubMed:20410020}.
CC   -!- PTM: N-glycosylated (PubMed:11790796, PubMed:23958596). N-
CC       glycosylation is important for maturation of the enzyme and normal
CC       subcellular location (PubMed:23958596).
CC       {ECO:0000269|PubMed:11790796, ECO:0000269|PubMed:23958596}.
CC   -!- SIMILARITY: Belongs to the AB hydrolase superfamily. Lipase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB53675.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB017494; BAA76877.1; -; mRNA.
DR   EMBL; AY358425; AAQ88791.1; -; mRNA.
DR   EMBL; AK001705; BAG50965.1; -; mRNA.
DR   EMBL; AK074828; BAC11233.1; -; mRNA.
DR   EMBL; AK300596; BAG62293.1; -; mRNA.
DR   EMBL; AK222790; BAD96510.1; -; mRNA.
DR   EMBL; AL110209; CAB53675.1; ALT_INIT; mRNA.
DR   EMBL; AC020978; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471092; EAW83217.1; -; Genomic_DNA.
DR   EMBL; BC011640; AAH11640.2; -; mRNA.
DR   EMBL; BC062605; AAH62605.1; -; mRNA.
DR   EMBL; AL389957; CAB97531.1; -; mRNA.
DR   CCDS; CCDS10864.1; -. [Q8NCC3-1]
DR   PIR; T14755; T14755.
DR   RefSeq; NP_036452.1; NM_012320.3. [Q8NCC3-1]
DR   UniGene; Hs.632199; -.
DR   PDB; 4X90; X-ray; 1.84 A; A/B/C/D=34-412.
DR   PDB; 4X91; X-ray; 2.30 A; A/B/C/D=34-412.
DR   PDB; 4X92; X-ray; 3.00 A; A=34-412.
DR   PDB; 4X93; X-ray; 2.60 A; A/B=34-412.
DR   PDB; 4X94; X-ray; 2.70 A; A=34-412.
DR   PDB; 4X95; X-ray; 3.08 A; A/B=34-412.
DR   PDB; 4X97; X-ray; 2.65 A; A/B/C/D=34-412.
DR   PDBsum; 4X90; -.
DR   PDBsum; 4X91; -.
DR   PDBsum; 4X92; -.
DR   PDBsum; 4X93; -.
DR   PDBsum; 4X94; -.
DR   PDBsum; 4X95; -.
DR   PDBsum; 4X97; -.
DR   ProteinModelPortal; Q8NCC3; -.
DR   SMR; Q8NCC3; -.
DR   BioGrid; 117181; 2.
DR   IntAct; Q8NCC3; 2.
DR   MINT; MINT-1403291; -.
DR   STRING; 9606.ENSP00000219345; -.
DR   BindingDB; Q8NCC3; -.
DR   ChEMBL; CHEMBL4986; -.
DR   ESTHER; human-PLA2G15; PC-sterol_acyltransferase.
DR   iPTMnet; Q8NCC3; -.
DR   PhosphoSitePlus; Q8NCC3; -.
DR   BioMuta; PLA2G15; -.
DR   DMDM; 44888104; -.
DR   EPD; Q8NCC3; -.
DR   MaxQB; Q8NCC3; -.
DR   PaxDb; Q8NCC3; -.
DR   PeptideAtlas; Q8NCC3; -.
DR   PRIDE; Q8NCC3; -.
DR   DNASU; 23659; -.
DR   Ensembl; ENST00000219345; ENSP00000219345; ENSG00000103066. [Q8NCC3-1]
DR   Ensembl; ENST00000413021; ENSP00000394197; ENSG00000103066. [Q8NCC3-2]
DR   GeneID; 23659; -.
DR   KEGG; hsa:23659; -.
DR   UCSC; uc002evr.4; human. [Q8NCC3-1]
DR   CTD; 23659; -.
DR   DisGeNET; 23659; -.
DR   GeneCards; PLA2G15; -.
DR   HGNC; HGNC:17163; PLA2G15.
DR   HPA; HPA041702; -.
DR   HPA; HPA041727; -.
DR   MIM; 609362; gene.
DR   neXtProt; NX_Q8NCC3; -.
DR   OpenTargets; ENSG00000103066; -.
DR   PharmGKB; PA164724567; -.
DR   eggNOG; KOG2369; Eukaryota.
DR   eggNOG; ENOG410Y9CF; LUCA.
DR   GeneTree; ENSGT00390000004902; -.
DR   HOGENOM; HOG000238654; -.
DR   InParanoid; Q8NCC3; -.
DR   KO; K06129; -.
DR   OMA; EMIEEMH; -.
DR   OrthoDB; EOG091G07S3; -.
DR   PhylomeDB; Q8NCC3; -.
DR   TreeFam; TF313258; -.
DR   ChiTaRS; PLA2G15; human.
DR   GeneWiki; LYPLA3_(gene); -.
DR   GenomeRNAi; 23659; -.
DR   PRO; PR:Q8NCC3; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103066; -.
DR   CleanEx; HS_PLA2G15; -.
DR   ExpressionAtlas; Q8NCC3; baseline and differential.
DR   Genevisible; Q8NCC3; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0047499; F:calcium-independent phospholipase A2 activity; ISS:UniProtKB.
DR   GO; GO:0004622; F:lysophospholipase activity; TAS:ProtInc.
DR   GO; GO:0008374; F:O-acyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0005543; F:phospholipid binding; TAS:ProtInc.
DR   GO; GO:0006672; P:ceramide metabolic process; IDA:UniProtKB.
DR   GO; GO:0009062; P:fatty acid catabolic process; TAS:ProtInc.
DR   GO; GO:0006650; P:glycerophospholipid metabolic process; IDA:UniProtKB.
DR   GO; GO:0034638; P:phosphatidylcholine catabolic process; ISS:UniProtKB.
DR   GO; GO:0046338; P:phosphatidylethanolamine catabolic process; ISS:UniProtKB.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR003386; LACT/PDAT_acylTrfase.
DR   Pfam; PF02450; LCAT; 2.
DR   SUPFAM; SSF53474; SSF53474; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Alternative splicing;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Fatty acid metabolism; Glycoprotein; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Lysosome; Membrane; Reference proteome; Secreted;
KW   Signal; Transferase.
FT   SIGNAL        1     33       {ECO:0000269|PubMed:10092508,
FT                                ECO:0000269|PubMed:15340161}.
FT   CHAIN        34    412       Group XV phospholipase A2.
FT                                /FTId=PRO_0000017808.
FT   ACT_SITE    198    198       Acyl-ester intermediate.
FT                                {ECO:0000244|PDB:4X97, ECO:0000255,
FT                                ECO:0000269|PubMed:25727495}.
FT   ACT_SITE    360    360       Charge relay system.
FT                                {ECO:0000305|PubMed:25727495}.
FT   ACT_SITE    392    392       Charge relay system.
FT                                {ECO:0000305|PubMed:25727495}.
FT   BINDING      46     46       Substrate; via amide nitrogen.
FT                                {ECO:0000244|PDB:4X97,
FT                                ECO:0000305|PubMed:25727495}.
FT   BINDING     199    199       Substrate; via amide nitrogen.
FT                                {ECO:0000244|PDB:4X95,
FT                                ECO:0000305|PubMed:25727495}.
FT   CARBOHYD     99     99       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4X90,
FT                                ECO:0000244|PDB:4X91,
FT                                ECO:0000244|PDB:4X92,
FT                                ECO:0000244|PDB:4X93,
FT                                ECO:0000244|PDB:4X94,
FT                                ECO:0000244|PDB:4X95,
FT                                ECO:0000244|PDB:4X97, ECO:0000255,
FT                                ECO:0000269|PubMed:25727495}.
FT   CARBOHYD    273    273       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4X90,
FT                                ECO:0000244|PDB:4X91,
FT                                ECO:0000244|PDB:4X92,
FT                                ECO:0000244|PDB:4X93,
FT                                ECO:0000244|PDB:4X94,
FT                                ECO:0000244|PDB:4X95,
FT                                ECO:0000244|PDB:4X97, ECO:0000255,
FT                                ECO:0000269|PubMed:25727495}.
FT   CARBOHYD    289    289       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4X90,
FT                                ECO:0000244|PDB:4X91,
FT                                ECO:0000244|PDB:4X92,
FT                                ECO:0000244|PDB:4X93,
FT                                ECO:0000244|PDB:4X94,
FT                                ECO:0000244|PDB:4X95,
FT                                ECO:0000244|PDB:4X97, ECO:0000255,
FT                                ECO:0000269|PubMed:25727495}.
FT   CARBOHYD    398    398       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4X90,
FT                                ECO:0000244|PDB:4X91,
FT                                ECO:0000244|PDB:4X92,
FT                                ECO:0000244|PDB:4X93,
FT                                ECO:0000244|PDB:4X94,
FT                                ECO:0000244|PDB:4X95,
FT                                ECO:0000244|PDB:4X97, ECO:0000255,
FT                                ECO:0000269|PubMed:25727495}.
FT   DISULFID     65     89       {ECO:0000244|PDB:4X90,
FT                                ECO:0000244|PDB:4X91,
FT                                ECO:0000244|PDB:4X92,
FT                                ECO:0000244|PDB:4X93,
FT                                ECO:0000244|PDB:4X94,
FT                                ECO:0000244|PDB:4X95,
FT                                ECO:0000244|PDB:4X97,
FT                                ECO:0000269|PubMed:25727495}.
FT   VAR_SEQ      43    114       VPGDLGNQLEAKLDKPTVVHYLCSKKTESYFTIWLNLELLL
FT                                PVIIDCWIDNIRLVYNKTSRATQFPDGVDVR -> GWFTTK
FT                                HPGPPSFLMVWMYVSLALGRPSHWSSWTPAKAAWVPISTPW
FT                                WRALWAGATHGVRMSEGLPMTGAEP (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056689.
FT   VAR_SEQ     115    208       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056690.
FT   MUTAGEN      46     46       D->A: Decreases phospholipase and
FT                                transacetylase activity. Has no effect on
FT                                association with membranes.
FT                                {ECO:0000269|PubMed:25727495}.
FT   MUTAGEN      83     83       L->S: No effect on phospholipase
FT                                activity. Strongly decreases
FT                                transacetylase activity and association
FT                                with membranes.
FT                                {ECO:0000269|PubMed:25727495}.
FT   MUTAGEN      85     85       V->S: No effect on phospholipase
FT                                activity. Strongly decreases
FT                                transacetylase activity and association
FT                                with membranes.
FT                                {ECO:0000269|PubMed:25727495}.
FT   MUTAGEN      99     99       N->A: Loss of glycosylation site. Leads
FT                                to retention in the endoplasmic reticulum
FT                                and nearly abolishes the production of
FT                                the mature, active enzyme.
FT                                {ECO:0000269|PubMed:23958596}.
FT   MUTAGEN     198    198       S->A: Abolishes phospholipase and
FT                                transacetylase activity. Abolishes
FT                                association with membranes.
FT                                {ECO:0000269|PubMed:25727495}.
FT   MUTAGEN     235    235       K->A: No effect on phospholipase
FT                                activity. Abolishes transacetylase
FT                                activity. Has no effect on association
FT                                with membranes.
FT                                {ECO:0000269|PubMed:25727495}.
FT   MUTAGEN     273    273       N->A: Loss of glycosylation site. Mildly
FT                                reduces production of the mature, active
FT                                enzyme. {ECO:0000269|PubMed:23958596}.
FT   MUTAGEN     289    289       N->A: Loss of glycosylation site. Mildly
FT                                reduces production of the mature, active
FT                                enzyme. {ECO:0000269|PubMed:23958596}.
FT   MUTAGEN     362    362       T->A: No effect on phospholipase
FT                                activity. Strongly decreases
FT                                transacetylase activity and abolishes
FT                                association with membranes.
FT                                {ECO:0000269|PubMed:25727495}.
FT   MUTAGEN     398    398       N->A: Loss of glycosylation site.
FT                                Slightly reduces production of the
FT                                mature, active enzyme.
FT                                {ECO:0000269|PubMed:23958596}.
FT   CONFLICT     94     94       I -> T (in Ref. 4; BAD96510).
FT                                {ECO:0000305}.
FT   CONFLICT    370    370       Q -> R (in Ref. 3; BAC11233).
FT                                {ECO:0000305}.
FT   STRAND       40     43       {ECO:0000244|PDB:4X90}.
FT   STRAND       51     56       {ECO:0000244|PDB:4X90}.
FT   STRAND       73     77       {ECO:0000244|PDB:4X90}.
FT   HELIX        79     82       {ECO:0000244|PDB:4X90}.
FT   HELIX        86     94       {ECO:0000244|PDB:4X90}.
FT   STRAND       97     99       {ECO:0000244|PDB:4X90}.
FT   TURN        100    103       {ECO:0000244|PDB:4X90}.
FT   STRAND      104    106       {ECO:0000244|PDB:4X90}.
FT   STRAND      111    114       {ECO:0000244|PDB:4X90}.
FT   HELIX       122    125       {ECO:0000244|PDB:4X90}.
FT   STRAND      126    128       {ECO:0000244|PDB:4X90}.
FT   HELIX       133    135       {ECO:0000244|PDB:4X90}.
FT   STRAND      136    138       {ECO:0000244|PDB:4X90}.
FT   HELIX       139    147       {ECO:0000244|PDB:4X90}.
FT   TURN        153    155       {ECO:0000244|PDB:4X90}.
FT   STRAND      156    158       {ECO:0000244|PDB:4X90}.
FT   HELIX       167    169       {ECO:0000244|PDB:4X90}.
FT   HELIX       171    188       {ECO:0000244|PDB:4X90}.
FT   STRAND      192    197       {ECO:0000244|PDB:4X90}.
FT   HELIX       200    209       {ECO:0000244|PDB:4X90}.
FT   HELIX       213    219       {ECO:0000244|PDB:4X90}.
FT   STRAND      220    227       {ECO:0000244|PDB:4X90}.
FT   HELIX       235    242       {ECO:0000244|PDB:4X90}.
FT   HELIX       253    262       {ECO:0000244|PDB:4X90}.
FT   HELIX       264    268       {ECO:0000244|PDB:4X90}.
FT   TURN        273    275       {ECO:0000244|PDB:4X90}.
FT   STRAND      281    284       {ECO:0000244|PDB:4X90}.
FT   STRAND      289    291       {ECO:0000244|PDB:4X90}.
FT   HELIX       292    294       {ECO:0000244|PDB:4X95}.
FT   HELIX       295    301       {ECO:0000244|PDB:4X90}.
FT   HELIX       305    314       {ECO:0000244|PDB:4X90}.
FT   STRAND      328    336       {ECO:0000244|PDB:4X90}.
FT   STRAND      338    343       {ECO:0000244|PDB:4X90}.
FT   TURN        347    349       {ECO:0000244|PDB:4X90}.
FT   STRAND      353    364       {ECO:0000244|PDB:4X90}.
FT   HELIX       365    367       {ECO:0000244|PDB:4X90}.
FT   HELIX       368    374       {ECO:0000244|PDB:4X90}.
FT   TURN        375    377       {ECO:0000244|PDB:4X90}.
FT   STRAND      382    388       {ECO:0000244|PDB:4X90}.
FT   HELIX       394    397       {ECO:0000244|PDB:4X90}.
FT   HELIX       399    410       {ECO:0000244|PDB:4X90}.
SQ   SEQUENCE   412 AA;  46658 MW;  1FEA8A5783AF050A CRC64;
     MGLHLRPYRV GLLPDGLLFL LLLLMLLADP ALPAGRHPPV VLVPGDLGNQ LEAKLDKPTV
     VHYLCSKKTE SYFTIWLNLE LLLPVIIDCW IDNIRLVYNK TSRATQFPDG VDVRVPGFGK
     TFSLEFLDPS KSSVGSYFHT MVESLVGWGY TRGEDVRGAP YDWRRAPNEN GPYFLALREM
     IEEMYQLYGG PVVLVAHSMG NMYTLYFLQR QPQAWKDKYI RAFVSLGAPW GGVAKTLRVL
     ASGDNNRIPV IGPLKIREQQ RSAVSTSWLL PYNYTWSPEK VFVQTPTINY TLRDYRKFFQ
     DIGFEDGWLM RQDTEGLVEA TMPPGVQLHC LYGTGVPTPD SFYYESFPDR DPKICFGDGD
     GTVNLKSALQ CQAWQSRQEH QVLLQELPGS EHIEMLANAT TLAYLKRVLL GP
//
